A REVIEW ON: FORMULATION, TECHNOLOGICAL AND BENEFICIAL ASPECTS OF ORAL DISPERSIBLE TABLETS

This review is about oral dispersible tablets a novel approach in drug  delivery systems that are now a day’s more focused in formulation world,  and laid a new path that, helped the patients to build their compliance level  with the therapy, also reduced the cost and ease the administration  especi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International Journal of Pharma Professional’s Research (IJPPR) 2023-02, Vol.14 (1), p.92-99
Hauptverfasser: Agarwal, Shivendra, Misra, Raghvendra
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This review is about oral dispersible tablets a novel approach in drug  delivery systems that are now a day’s more focused in formulation world,  and laid a new path that, helped the patients to build their compliance level  with the therapy, also reduced the cost and ease the administration  especially in case of pediatrics and geriatrics. Oral dispersible tablets are  advantageous for pediatric, geriatric mentally ill, nausea patients who have  difficulty in swallowing conventional tablets and capsules. Using various  excipients, evaluation tests marketed formulation and drugs used in the  research area. The advantages of mouth dissolving dosage form are  increasingly being recognized in both, industry and academia. Their  growing importance has been underlined recently when European  Pharmacopoeia adopted the term “Oral dispersible Tablet” as tablet that is  to be place in the mouth where it disperses rapidly before swallowing.  When ODTs are put on tongue they disintegrate instantaneously, releasing  the drug which dissolve or disperses in the saliva. Some drugs are absorbed  from the mouth, pharynx and esophagus as the saliva passes down in to the  stomach. In such cases, bioavailability of a drug is significantly greater than  those observed from conventional tablet dosage form. 
ISSN:2249-3948
0976-6723
DOI:10.48165/ijppronline.2023.14108